Myriad Genetics (MYGN) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Price: $4.33 -6.48%
EPS Growth %: -220.0%
Financial Fact:
Earnings per diluted share: -0.02
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -220.0%
Financial Fact:
Earnings per diluted share: -0.02
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q4 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $211 million versus the consensus estimate of $213.31 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- XORTX to voluntarily delist from TSX Venture Exchange
- TechCreate Group faces NYSE American delisting proceedings
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
